The role of MAPK pathways in the action of chemotherapeutic drugs. [electronic resource]
Producer: 20021220Description: 1831-8 p. digitalISSN:- 0143-3334
- Adenocarcinoma -- pathology
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Breast Neoplasms -- pathology
- Carcinoma, Squamous Cell -- pathology
- Cell Cycle -- drug effects
- Ceramides -- pharmacology
- Enzyme Activation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Etoposide -- pharmacology
- Female
- Flavonoids -- pharmacology
- HeLa Cells -- drug effects
- Humans
- Imidazoles -- pharmacology
- MAP Kinase Signaling System -- drug effects
- Microtubules -- drug effects
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Neoplasm Proteins -- antagonists & inhibitors
- Paclitaxel -- pharmacology
- Pyridines -- pharmacology
- Skin Neoplasms -- pathology
- Topoisomerase II Inhibitors
- Tumor Cells, Cultured -- drug effects
- Tumor Stem Cell Assay
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.